Candidozyma auris Outbreak and Its Effective Control in a General Hospital
Authors:
- Flora V. KontopidouFlora V. Kontopidou
- Maria AntonopoulouMAMaria Antonopoulou
- Anastasia VotsiAVAnastasia Votsi
- Vassiliki PapoutsakiVPVassiliki Papoutsaki
- Vassiliki BereriVBVassiliki Bereri
- Evangelia KourkoulouEKEvangelia Kourkoulou
- Amalia RompolaARAmalia Rompola
- Georgia TsokouGTGeorgia Tsokou
- Anna PavliAPAnna Pavli
- Olga Maria KoutanteliaOKOlga Maria Koutantelia
- Maria SiopiMSMaria Siopi
- Sevasti LeventakiSevasti Leventaki
Open Access
- 5 June 2025
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 14 (6) , 579
Abstract
Background/Objectives: Candidozyma auris (C. auris) is a multidrug-resistant pathogen recognized as a serious global public health threat. Herein, we report a C. auris outbreak that was successfully contained in a general hospital located in Athens, Greece. Methods: This study was conducted between December 2021 and December 2023. Upon identification of the first imported case of C. auris, the following infection control measures were applied in a stepwise approach: the promotion of hand hygiene, contact precautions and isolation, chlorhexidine gluconate bathing of patients, enhanced environmental cleaning, and active surveillance cultures of all high-risk patients upon admission. Active surveillance cultures were performed weekly in non-colonized ICU patients. Results: A total of 1564 screening samples from 890 patients were analyzed. Sixty-three patients were identified to be colonized and three to be infected with C. auris. After implementing screening and enhanced environmental cleaning, the quarterly incidence of hospital-acquired cases decreased from 0.37 to 0.04 cases per 1000 patient-days (slope of linear trend: −0.08; 95% CI: −0.16 to −0.0004; p = 0.05), despite the continuous inflow of already colonized patients. Conclusions: A bundle of infection control measures, including active surveillance cultures upon admission and enhanced environmental cleaning, can contain C. auris dissemination in acute healthcare settings.Keywords
Funding Information
- Special Account for Research Grants of the National and Kapodistrian University of Athens (17287)
This publication has 35 references indexed in Scilit:
- Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic studyThe Lancet Microbe, 2024
- Candida auris in Greek healthcare facilities: Active surveillance results on first cases and outbreaks from eleven hospitals within Attica regionJournal of Medical Mycology, 2024
- Strategies to Prevent Transmission of Candida auris in Healthcare SettingsCurrent Fungal Infection Reports, 2023
- In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida aurisClinical Microbiology and Infection, 2021
- Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strainsJournal of Infection and Chemotherapy, 2019
- Candida auris: a global fungal public health threatThe Lancet Infectious Diseases, 2018
- Candida auris : An emerging multidrug-resistant pathogenInternational Journal of Infectious Diseases, 2017
- Leadership and management for infection prevention and control: what do we have and what do we need?Journal of Hospital Infection, 2016
- Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infectionIntensive Care Medicine, 2008
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987